Qualitative and Quantitative Analysis of Certain Aspects of the Cytotoxic and Genotoxic Hazard of Hospital Wastewaters by Using a Range of

cytotoxicity genotoxicity health hazard hospital effluents in vitro testing microbiota contamination wastewater safety

Journal

Alternatives to laboratory animals : ATLA
ISSN: 0261-1929
Titre abrégé: Altern Lab Anim
Pays: England
ID NLM: 8110074

Informations de publication

Date de publication:
Historique:
pubmed: 30 4 2021
medline: 9 6 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Health care facilities and hospitals generate significant amounts of wastewater which are released into the sewage system, either after a preliminary treatment or without any further treatment. Hospital wastewater may contain large amounts of hazardous chemicals and pharmaceuticals, some of which cannot be eliminated entirely by wastewater treatment plants. Moreover, hospital effluents may be loaded with a plethora of pathogenic microorganisms or other microbiota and microbiome residues. The need to monitor hospital effluents for their genotoxic hazard is of high importance, as detailed information is scarce. DNA-based information can be acquired directly from samples through the application of various molecular methods, while cell-based biomonitoring assays can provide important information about impaired cellular pathways or mechanisms of toxicity without prior knowledge of the identity of each toxicant. In our study, we evaluated samples of chlorinated hospital wastewater discharged into the sewage system after this disinfection process. The assessment of cytotoxicity, genotoxicity and mutagenicity of the hospital effluents was performed

Identifiants

pubmed: 33910377
doi: 10.1177/02611929211004956
doi:

Substances chimiques

Waste Water 0
Water Pollutants, Chemical 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-48

Auteurs

Stanislav Janousek (S)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.

Alena Vlkova (A)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.
Faculty of Environmental Sciences, 48371Czech University of Life Sciences Prague, Prague, Czech Republic.

Gabriela Jirova (G)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.
Faculty of Environmental Sciences, 48371Czech University of Life Sciences Prague, Prague, Czech Republic.

Kristina Kejlova (K)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.

Daniel Krsek (D)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.

Dagmar Jirova (D)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.

Helena Kandarova (H)

Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.

Zdenka Wittlingerova (Z)

Faculty of Environmental Sciences, 48371Czech University of Life Sciences Prague, Prague, Czech Republic.

Tuula Heinonen (T)

FICAM, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Marika Mannerstrom (M)

FICAM, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Marek Maly (M)

Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH